Controlling the HIV Epidemic with Antiretrovirals: Avoiding the Cost of Inaction

published on September 18, 2014

The International Association of Providers of AIDS Care (IAPAC), in collaboration with AIDS Healthcare Foundation (AHF), Public Health England (PHE), and the Joint United Nations Programme on HIV/AIDS (UNAIDS), will host a summit aimed at leveraging antiretrovirals to end AIDS-related mortality and prevent new HIV infections.

The summit, Controlling the HIV Epidemic with Antiretrovirals: Avoiding the Cost of Inaction, will take place 18-19 September 2014 at the Royal Garden Hotel in London, and will feature data related to and discussion about the implementation of combination prevention, including treatment as prevention (TasP) and pre-exposure prophylaxis (PrEP). In addition, the summit will provide a forum for exploring HIV care and prevention continua optimization to achieve antiretroviral therapy's maximum therapeutic and preventative effects.

The summit will be webcast live each day of the summit (UK time). Registration is free-of-charge. To access the webcast at any time during the summit, enter the following URL address into your browser or click here:

http://www.psaveurope.com/iapac

PROGRAM

The summit will be co-chaired by Kenneth H. Mayer, MD (Harvard University/Fenway Institute, USA) and Julio SG Montaner, MD (British Columbia Centre for Excellence in HIV/AIDS, Canada).

This year’s program builds upon the significant momentum gained from the 2012 and 2013 summits. The 2012 summit allowed IAPAC to generate a Consensus Statement released at the XIX International AIDS Conference in Washington, DC, USA. And, last year’s summit is the subject of a 1 July 2014, IAPAC-sponsored supplement to Clinical Infectious Diseases. Featured in the supplement is an editorial (available as an Open Access manuscript) that serves as the foundation for the 2014 summit program.

For more Information CLICK HERE

Tags:

Julio Montaner

BC Centre for Excellence in HIV/AIDS

Search form

Controlling the HIV Epidemic with Antiretrovirals: Avoiding the Cost of Inaction

Search form